Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Merit Medical Systems (MMSI)
NASDAQ:MMSI
MMSI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$70.70 - $111.45
Previous CloseN/A
Volume49.13K
Average Volume (3M)502.05K
Market Cap
$6.16B
Enterprise Value$6.18B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)51.8
Beta0.44
Next Earnings
Feb 25, 2025EPS Estimate
0.83Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.04
Shares Outstanding58,279,408
10 Day Avg. Volume429,706
30 Day Avg. Volume502,050
Standard Deviation0.08
R-Squared0.30
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.68
Price to Cash Flow (P/CF)32.80
P/FCF Ratio41.40
Enterprise Value/Market Cap1.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.58
Enterprise Value/Ebitda21.43
Forecast
1Y Price Target
$118.88Price Target Upside12.51% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
---
Merit Medical Systems News
PremiumCompany Announcements
Merit Medical Celebrates FDA Approval of WRAPSODY™
PremiumCompany Announcements
Merit Medical Systems Reveals Strong 2024 Revenue Growth
---
Bulls Say, Bears Say
Bulls Say
Market PotentialThe WRAPSODY has the potential to become the first-line therapy for a significant market opportunity exceeding $550 million.
Product ApprovalMerit Medical has received U.S. approval and commercialization for its Wrapsody device, which is intended to improve long-term vessel patency in dialysis patients.
Revenue GrowthMerit Medical preannounced 2024 revenue above consensus expectations, indicating strong performance.
Bears Say
Price StrategyWrapsody will be priced at a premium to other covered stents, but Merit has created pricing strategies for different sites of care designed not to financially burden the facilities.
Reimbursement ChallengesEarly adoption of Wrapsody is likely dependent on reimbursement given the cost-sensitive market.
Revenue ForecastManagement expects WRAPSODY to generate $7-9M of sales in 2025; while this is lower than prior forecasts, it is expected to prove conservative.
---
Ownership Overview
2.42% Insiders
38.86% Mutual Funds
27.56% Other Institutional Investors
4.84% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MMSI FAQ
What was Merit Medical Systems’s price range in the past 12 months?
Merit Medical Systems lowest stock price was $70.70 and its highest was $111.45 in the past 12 months.
What is Merit Medical Systems’s market cap?
Merit Medical Systems’s market cap is $6.16B.
When is Merit Medical Systems’s upcoming earnings report date?
Merit Medical Systems’s upcoming earnings report date is Feb 25, 2025 which is in 3 days.
How were Merit Medical Systems’s earnings last quarter?
Merit Medical Systems released its earnings results on Oct 30, 2024. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.798 by $0.062.
Is Merit Medical Systems overvalued?
According to Wall Street analysts Merit Medical Systems’s price is currently Undervalued.
Does Merit Medical Systems pay dividends?
Merit Medical Systems does not currently pay dividends.
What is Merit Medical Systems’s EPS estimate?
Merit Medical Systems’s EPS estimate is 0.83.
How many shares outstanding does Merit Medical Systems have?
Merit Medical Systems has 58,279,408 shares outstanding.
What happened to Merit Medical Systems’s price movement after its last earnings report?
Merit Medical Systems reported an EPS of $0.86 in its last earnings report, beating expectations of $0.798. Following the earnings report the stock price went up 3.962%.
Which hedge fund is a major shareholder of Merit Medical Systems?
Currently, no hedge funds are holding shares in MMSI
---
Merit Medical Systems Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$118.88 (12.51% Upside)
$118.88 (12.51% Upside)
Blogger Sentiment
Bullish
MMSI Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 2.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $547.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.7%
Last 30 Days ▲ 7.9%
Last 30 Days ▲ 7.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
32.15%
12-Months-Change
Fundamentals
Return on Equity
9.40%
Trailing 12-Months
Asset Growth
31.49%
Trailing 12-Months
Company Description
Merit Medical Systems
Merit Medical Systems, Inc. engages in the manufacture and market of proprietary disposable medical devices. It operates through Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates advanced non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger and William Padilla in July 1987 and is headquartered in South Jordan, UT.
---
MMSI Company Deck
---
MMSI Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
Merit Medical delivered strong revenue and profitability growth, alongside significant free cash flow and positive clinical trial results for WRAPSODY. However, challenges remain in the OEM segment due to supply chain issues and a decline in China sales. The strategic acquisition of Cook Medical's portfolio is expected to enhance future growth.Read More>---
MMSI Stock 12 Month Forecast
Average Price Target
$118.88
▲(12.51% Upside)
Technical Analysis
Abbott Laboratories
―
Boston Scientific
―
Hologic
―
Medtronic
―
Zimmer Biomet Holdings
―
Best Analysts Covering MMSI
1 Year
1 Year Success Rate
18/20 ratings generated profit
1 Year Average Return
+18.09%
assigned a buy rating 25 days ago
Copying Jason Bednar's trades and holding each position for 1 Year would result in 90.00% of your transactions generating a profit, with an average return of +18.09% per trade.
---